Venipharm and Lanco Medical Group Announce Strategic Partnership to Expand Market Reach into Central America and Mexico

[Miami, 2023.10.18] – Venipharm,a leading French pharmaceutical company specializing in generics and pharmaceutical development, has announced a groundbreaking strategic partnership with Lanco Medical Group, a renowned player in the pharmaceutical industry based in the United States. This innovative collaboration aims to extend the reach of high-quality pharmaceutical solutions to Central America and Mexico.

Venipharm, known for its dedication to providing high-quality pharmaceutical solutions, has established itself as an independent and customer-centric enterprise with an unwavering commitment to excellence. The company boasts a dynamic team of chemists, pharmacists, and engineers who have garnered a stellar reputation for their expertise in product development and regulatory affairs. With a strong foothold in the European markets, Venipharm is exceptionally well-positioned to secure marketing authorizations and offer a long-term supply of finished dosage forms.

Lanco Medical Group, a respected name in the pharmaceutical landscape, shares Venipharm’s commitment to innovation and customer satisfaction. This collaboration represents a pivotal moment for both organizations as they embark on a joint endeavor to expand their market presence in Central America and Mexico.

Key highlights of the strategic partnership include:
1. Regional Expansion with LMG: Lanco Medical Group (LMG), a trusted distributor with extensive regional expertise in Central America and Mexico, will serve as the gateway for Venipharm’s products. This strategic partnership aligns with LMG’s commitment to ensuring easy access to high-quality pharmaceuticals in the region.
2.  Product Commercialization: Lanco Medical Group and Venipharm will work closely together to introduce one of Venipharm’s exceptional products to the Central American and Mexican healthcare sectors. This collaboration ensures that patients in these regions gain access to high-quality pharmaceutical solutions.
3.  Synergy of Expertise: By combining Venipharm’s pharmaceutical development proficiency with Lanco Medical Group market knowledge and regional influence, the partnership is primed to create a positive impact on healthcare accessibility and product availability.
4.  A Shared Vision: Lanco Medical Group, a key player in this collaboration, is guided by a clear purpose, mission, and vision. LMG’s mission is to provide multinational pharmaceutical companies with a seamless path to success in Latin America, eliminating barriers and complexities. Their vision is to be the preferred ally for pharmaceutical industry leaders, contributing to sustainable growth and bringing advanced therapies to those in need.

Prev post
Next post

Leave A Reply